Yıl: 2023 Cilt: 30 Sayı: 11 Sayfa Aralığı: 1377 - 1382 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2022.07.226 İndeks Tarihi: 30-11-2023

Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study

Öz:
Aim: The aim of the study is to investigate the relationship of subclinical inflammatory factors Platelet crit (PCT), Neutrophil-lymphocyte ratio (NLR), Monocyte-lymphocyte ratio (MLR), Platelet-lymphocyte ratio (PLR) obtained from complete blood count (CBC) with Abortion Immunes (AI) and obstetric results. In recent years, studies reveal that subclinical inflammatory markers can be used as an indicator of the inflammatory process in many diseases. Few studies have evaluated indicators of inflammation and postpartum outcomes in abortion imminent patients. Materials and Methods: The study was conducted between January 2020 and January 2021. A total of 429 pregnant women, 203 of whom were pregnant with AI and 226 who were healthy, were included in the study. Results: PCT, NLR, and MLR values were significantly higher and PLR values were low in the AI group (p<0.05). PCT > 0.22, NLR > 2.29, and MLR > 0.20 were significantly associated with an increased risk of AI (p<0.05). PLR value above 135.5 was associated with the normal group. There was a significant difference between the group whose pregnancy was terminated by abortion and the group who gave birth in terms of PCT, NLR, MLR, and PLR values. PCT, NLR, and MLR values were high in the abortion group, and PLR values were low (p<0.05). Premature birth was developed in 11.3% (n=15) of AI patients. There was a significant difference between the preterm and term pregnancy in terms of PCT, NLR, MLR, and PLR levels (p<0.005). PCT, NLR, and MLR values were high and PLR levels were low in pregnant women who gave birth prematurely. Conclusion: We think that close follow-up of abortion imminent patients with high levels of these inflammatory factors is appropriate.
Anahtar Kelime: Abortus imminens Inflammation Platelet crit Neutrophil to lymphocyte ratio Platelet to lymphocyte ratio Monocytes to lymphocyte ratio

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Nanda K, Lopez LM, Grimes DA et al. Expectant care versus surgical treatment for miscarriage. Cochrane Database of Systematic Reviews 2012; 3.
  • 2. Tongsong T, Srisomboon J, Wanapirak C et al. Pregnancy outcome of threatened abortion with demonstrable fetal cardiac activity: a cohort study. Journal of Obstetrics and Gynaecology 1995; 21(4), 331-335.
  • 3. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. The lancet 2008; 371(9606), 75-84.
  • 4. Kaplanoglu M, Yuce T, Bulbul M. Decreased mean platelet volume is associated with the developing stage of fetoplacental unit in spontaneous abortion. International Journal of Clinical and Experimental Medicine 2015; 8(7), 11301.
  • 5. Yildirim M, Turkyilmaz E, Avsar AF. Preoperative neutrophilto-lymphocyte ratio has a better predictive capacity in diagnosing tubo-ovarian abscess. Gynecologic and Obstetric Investigation 2015; 80(4), 234-239.
  • 6. Weiss G. Anemia of chronic disorders: new diagnostic tools and new treatment strategies. In Seminars in hematology 2015; Vol. 52, No. 4, pp. 313-320). WB Saunders.
  • 7. Bıyık I, Albayrak M, Keskin Fatih. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in missed abortion. Revista Brasileira de Ginecologia e Obstetrícia, 2020, 42: 235-239.
  • 8. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011; 17:47-58.
  • 9. Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6:98.
  • 10. Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2015; 26:680-1.
  • 11. Nora I, Shridhar R, Huston J, Meredith K. The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies. J Gastrointest Oncol 2018; 9(5):972-8.
  • 12. Ipek E, Yıldırım E, Cengiz M et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio and their relationship with canadian cardiovascular society angına classification in patients with chestpain. Ankara Med J 2016; 16(1):51-60.
  • 13. Aynıoglu O, Isık H, Sahbaz, A, Harma MI, Isık M, Kokturk, F. Can plateletcrit be a marker for recurrent pregnancy loss? Clinical and Applied Thrombosis/Hemostasis, 2016; 22(5), 447- 452.
  • 14. Al-Aghbary AAR, Almorish, MAW, Jaffar DWM, Al-Kahiry WM. Platelet indices in evaluation of patients with recurrent pregnancy loss. Asian Pacific Journal of Reproduction, 2018; 7(1), 15.
  • 15. Basama FM, Crosfill F. The out come of pregnancies in 182 women with threatened miscarriage. Arch Gynecol Obstet 2004; 270:86-90.
  • 16. Hill LM, Guzick D, Fries J, Hixson J. Fetal loss rate after ultrasonically documented cardiac activity between 6 and 14 weeks, menstrual age. J Clin Ultrasound 1991; 19:221-3.
  • 17. Chaouat G, Dubanchet S, Ledee N. Cytokines: important for implantation? J Asist ReprodGenet 2007; 24:491-505.
  • 18. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005; 26:44-62.
  • 19. Colak A, Zeytinli AM, Toprak B, Yılmaz N. Diagnostic values of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and procalcitonin in early diagnosis of bacteremia. Turk J Biochem 2020; 45:57-64.
  • 20. Sirin MC, Korkmaz S, Erturan I et al. (2020). Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis. An Bras Dermatol 2020; 95:575-82.
  • 21. Eraldemir FC. Prokalsitonin yerine nötrofil/lenfosit oranı: Bir seçenek olabilir mi? Türk Klinik Biyokimya Derg 2018; 16:11-6. 19 20 21.
  • 22. Akin MN, Kasap B, Yuvaci HU, Turhan N. Association between platelet indices and first trimester miscarriage. Blood Coagulation & Fibrinolysis, 2016; 27(5), 526-530.
  • 23. İbrahim K, Çağlar H, Tuğba EM. Evaluation of complete blood count parameters in the first trimester: an early indicator of miscarriage? J Clin Invest Surg. 2021; 6(1): 48-52. doi: 10.25083/2559.5555/6.1.9.
  • 24. Ata N, Kulhan M, Kulhan NG, Turkler C. Can neutrophillymphocyte and platelet-lymphocyte ratios predict threatened abortion and early pregnancy loss? Ginekol Pol 2020; 91:210-5.
  • 25. Jule EH, Hüseyin G, Eren BÖ et al. Evaluation of hemogram parameters in the diagnosis of ectopic pregnancy and threatened abortion. Cukurova Med J 2021; 46(1):63-69.
  • 26. Bas FY, Tola EN, Sak S. Cankaya BA. The role of complete blood inflammation markers in the prediction of spontaneous abortion. Pak J Med Sci 2018; 34:1381-5.
  • 27. Horasanlı JE, Görkemli, H, Özkaya EB et al. Ektopik gebelik ve düşük tehdidi tanısında hemogram parametrelerinin değerlendirilmesi. Cukurova Medical Journal, 2021; 46(1), 63-69.
  • 28. Evrenos AN, Çakır Güngör AN, Gülerman C. Obstetric outcomes of patiens with abortus imminens in the first trimester. Gynecology and Obstetric. March. 2014; Volume 289. Issue 3. Pp 499, 504.
  • 29. Johns J, Jaunıux E. Threatened miscarriage as an indicator of obstetric outcome. Obstetrics and Gynecology 2006; 107.4: 845- 850.
  • 30. Dadkhah F, Kashanian M, Eliasi G. A comparison between the pregnancy outcome in women with or without threatened abortion. Early Human Dev 2010; 86:193–196.
  • 31. Mulik V, Bethel J, Bhal K. A retrospective populationbased study of primigravid women on the potential effect of threatened miscarriage on obstetric outcome. J Obstet Gynaecol 2004; 24:249–253.
APA BAŞKIRAN Y, uckan K, Çeleğen İ (2023). Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. , 1377 - 1382. 10.5455/annalsmedres.2022.07.226
Chicago BAŞKIRAN YUSUF,uckan Kazım,Çeleğen İzzet Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. (2023): 1377 - 1382. 10.5455/annalsmedres.2022.07.226
MLA BAŞKIRAN YUSUF,uckan Kazım,Çeleğen İzzet Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. , 2023, ss.1377 - 1382. 10.5455/annalsmedres.2022.07.226
AMA BAŞKIRAN Y,uckan K,Çeleğen İ Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. . 2023; 1377 - 1382. 10.5455/annalsmedres.2022.07.226
Vancouver BAŞKIRAN Y,uckan K,Çeleğen İ Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. . 2023; 1377 - 1382. 10.5455/annalsmedres.2022.07.226
IEEE BAŞKIRAN Y,uckan K,Çeleğen İ "Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study." , ss.1377 - 1382, 2023. 10.5455/annalsmedres.2022.07.226
ISNAD BAŞKIRAN, YUSUF vd. "Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study". (2023), 1377-1382. https://doi.org/10.5455/annalsmedres.2022.07.226
APA BAŞKIRAN Y, uckan K, Çeleğen İ (2023). Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. Annals of Medical Research, 30(11), 1377 - 1382. 10.5455/annalsmedres.2022.07.226
Chicago BAŞKIRAN YUSUF,uckan Kazım,Çeleğen İzzet Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. Annals of Medical Research 30, no.11 (2023): 1377 - 1382. 10.5455/annalsmedres.2022.07.226
MLA BAŞKIRAN YUSUF,uckan Kazım,Çeleğen İzzet Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. Annals of Medical Research, vol.30, no.11, 2023, ss.1377 - 1382. 10.5455/annalsmedres.2022.07.226
AMA BAŞKIRAN Y,uckan K,Çeleğen İ Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. Annals of Medical Research. 2023; 30(11): 1377 - 1382. 10.5455/annalsmedres.2022.07.226
Vancouver BAŞKIRAN Y,uckan K,Çeleğen İ Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study. Annals of Medical Research. 2023; 30(11): 1377 - 1382. 10.5455/annalsmedres.2022.07.226
IEEE BAŞKIRAN Y,uckan K,Çeleğen İ "Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study." Annals of Medical Research, 30, ss.1377 - 1382, 2023. 10.5455/annalsmedres.2022.07.226
ISNAD BAŞKIRAN, YUSUF vd. "Subclinical inflammation markers and their impact on obstetric outcomes in abortus imminens: A case-control study". Annals of Medical Research 30/11 (2023), 1377-1382. https://doi.org/10.5455/annalsmedres.2022.07.226